InvestorsHub Logo
Followers 3183
Posts 208744
Boards Moderated 2
Alias Born 02/04/2004

Re: AngeloFoca post# 22228

Friday, 01/20/2017 1:32:11 PM

Friday, January 20, 2017 1:32:11 PM

Post# of 38634
Purdue Pharma Canada and IPCI both HQ'd in Canada about 1 hour away from 1 another...Purdue Pharma L.P. knows that they're powerless to stop the OxyContin market saturation/competition already en route by much more powerfully formulated abuse-deterrent candidates...so logic would certainly suggest that Purdue would most definitely have their eye on IPCI's PODRAS tech platform...since clearly they've already had their eye on Rexista and all OxyContin competitors coming.

So with PODRAS now part of IPCI's ever-evolving/emerging equation what better company is there out there right now than IPCI for Purdue to target if they really want to explore practical ways in possibly keeping their OxyContin dominance?

Also, I'm not saying that Purdue and IPCI could be discussing anything more than a potential Rexista and PODRAS partnership...but it is kind of intriguing just to think about the fact that IPCI's a publicly traded company while Purdue remains a privately held entity lol.

I know that last part is a huge stretch of the imagination...but the interest in Rexista and PODRAS certainly is not:)


Never buy or sell based on my posts! My posts are just my opinion!

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y